Sale!

ACADVL Gene Acyl-CoA Very Long-Chain Dehydrogenase Deficiency Genetic Test

Original price was: 5,600 د.إ.Current price is: 3,200 د.إ.

-43%

The ACADVL gene encodes for acyl-CoA dehydrogenase, an enzyme crucial for the breakdown of very long-chain fatty acids. A deficiency in this enzyme, known as Very Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCADD), can lead to serious metabolic problems, including hypoglycemia, liver dysfunction, and muscle weakness. It is a genetic condition that can manifest from infancy through adulthood, with varying degrees of severity.

To diagnose VLCADD, a genetic test targeting the ACADVL gene can be performed. This test identifies mutations in the ACADVL gene that are responsible for the condition. It is a critical step not only for confirming the diagnosis but also for guiding treatment plans and understanding the risk of passing the condition to future generations.

In the UAE, DNA Labs offers this specific genetic test for VLCADD. The cost of the test is 3200 AED. Conducting the test at DNA Labs UAE provides individuals and families with accurate, reliable results, leveraging advanced genetic testing technologies to ensure high-quality diagnostics. The test involves collecting a small sample of blood or saliva from the patient, which is then analyzed for mutations in the ACADVL gene. The process is straightforward, with results typically available within a few weeks, providing crucial information for managing and treating VLCADD effectively.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ACADVL Gene Acyl-CoA very long-chain dehydrogenase deficiency Genetic Test

At DNA Labs UAE, we offer the ACADVL Gene Acyl-CoA very long-chain dehydrogenase deficiency Genetic Test at a cost of AED 3200.0.

Test Details

The ACADVL gene is responsible for encoding the enzyme Acyl-CoA very long-chain dehydrogenase (ACADVL). Deficiency of this enzyme is a rare genetic disorder known as ACADVL deficiency.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that utilizes advanced sequencing technologies to analyze multiple genes simultaneously. In the case of ACADVL deficiency, NGS genetic testing can be used to identify mutations or variations in the ACADVL gene that may be associated with the disorder.

By analyzing the entire coding region of the ACADVL gene, NGS testing can provide a comprehensive assessment of genetic variations that may be causing the deficiency. This information can be helpful in confirming a diagnosis, understanding the genetic basis of the disorder, and potentially guiding treatment decisions.

It is important to note that NGS testing is typically performed by specialized laboratories and is ordered by healthcare professionals. The test involves obtaining a sample of DNA, usually through a blood or saliva sample, which is then sequenced using high-throughput sequencing platforms. The resulting data is then analyzed to identify any genetic variations or mutations in the ACADVL gene.

NGS genetic testing has revolutionized the field of genetic diagnostics, allowing for more efficient and cost-effective analysis of multiple genes simultaneously. It has greatly improved the ability to identify and understand genetic disorders like ACADVL deficiency, leading to improved diagnosis and management of affected individuals.

Test Components and Price

Test Name: ACADVL Gene Acyl-CoA very long-chain dehydrogenase deficiency Genetic Test

Components: NGS Technology

Price: AED 3200.0

Sample Condition

Blood

Report Delivery

3 to 4 Weeks

Test Type

Metabolic Disorders

Doctor

General Physician

Test Department

Genetics

Pre Test Information

A Genetic Counselling session is required to draw a pedigree chart of family members affected with Acyl-CoA very long-chain dehydrogenase deficiency before undergoing the ACADVL Gene Acyl-CoA very long-chain dehydrogenase deficiency NGS Genetic DNA Test. This will provide valuable information about the family history and help in understanding the inheritance pattern of the disorder.

Test Name ACADVL Gene Acyl-CoA very long-chain dehydrogenase deficiency Genetic Test
Components
Price 3200.0 AED
Sample Condition Blood
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ACADVL Gene Acyl-CoA very long-chain dehydrogenase deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Acyl-CoA very long-chain dehydrogenase deficiency
Test Details

ACADVL gene is responsible for encoding the enzyme Acyl-CoA very long-chain dehydrogenase (ACADVL). Deficiency of this enzyme is a rare genetic disorder known as ACADVL deficiency.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that utilizes advanced sequencing technologies to analyze multiple genes simultaneously. In the case of ACADVL deficiency, NGS genetic testing can be used to identify mutations or variations in the ACADVL gene that may be associated with the disorder.

By analyzing the entire coding region of the ACADVL gene, NGS testing can provide a comprehensive assessment of genetic variations that may be causing the deficiency. This information can be helpful in confirming a diagnosis, understanding the genetic basis of the disorder, and potentially guiding treatment decisions.

It is important to note that NGS testing is typically performed by specialized laboratories and is ordered by healthcare professionals. The test involves obtaining a sample of DNA, usually through a blood or saliva sample, which is then sequenced using high-throughput sequencing platforms. The resulting data is then analyzed to identify any genetic variations or mutations in the ACADVL gene.

NGS genetic testing has revolutionized the field of genetic diagnostics, allowing for more efficient and cost-effective analysis of multiple genes simultaneously. It has greatly improved the ability to identify and understand genetic disorders like ACADVL deficiency, leading to improved diagnosis and management of affected individuals.